MCM
STIM icon

Massar Capital Management’s Neuronetics STIM Stock Holding History

Massar Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-221,000
Closed -$320K – 374
2026
Q1 		$320K Hold
221,000
– – 0.03% 202
2025
Q4 		$305K Sell
221,000
-19,000
-8% -$39.8K 0.03% 279
2025
Q3 		$655K Buy
240,000
+20,000
+9% +$71K 0.09% 120
2025
Q2 		$768K Sell
220,000
-30,000
-12% -$118K 0.57% 52
2025
Q1 		$920K Buy
+250,000
New +$913K 1.03% 21

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massar Capital Management's STIM Position: Q2 2026 in Review

Massar Capital Management sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 221,000 shares — an estimated $320K sold.

Massar Capital Management first reported a position in STIM in Q1 2025 and held it in 5 quarters. The position peaked at $920K in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Massar Capital Management reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Massar Capital Management sold 221,000 Neuronetics shares in Q2 2026, an estimated $320K.
  • Massar Capital Management first reported a position in Neuronetics in Q1 2025 and held it in 5 quarters.
  • Massar Capital Management's Neuronetics position peaked at $920K in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Massar Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.